(2S)-N-[(3S)-5-[(6-bromo-2-methoxynaphthalen-1-yl)methyl]-1-[[4-(2,2-dimethylpropanoyl)phenyl]-hydroxymethyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide

C37H41BrN4O5 — CID 155199103

IUPAC(2S)-N-[(3S)-5-[(6-bromo-2-methoxynaphthalen-1-yl)methyl]-1-[[4-(2,2-dimethylpropanoyl)phenyl]-hydroxymethyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide
SMILESCN[C@@H](C)C(=O)N[C@H]1CN(C(O)c2ccc(C(=O)C(C)(C)C)cc2)c2ccccc2N(Cc2c(OC)ccc3cc(Br)ccc23)C1=O
InChIInChI=1S/C37H41BrN4O5/c1-22(39-5)34(44)40-29-21-42(35(45)24-13-11-23(12-14-24)33(43)37(2,3)4)31-10-8-7-9-30(31)41(36(29)46)20-28-27-17-16-26(38)19-25(27)15-18-32(28)47-6/h7-19,22,29,35,39,45H,20-21H2,1-6H3,(H,40,44)/t22-,29-,35?/m0/s1
InChIKeyGBUSEYJMYGTENS-HUINHVGJSA-N
MW701.66 g/mol
LogP5.98
Rot. Bonds9

About (2S)-N-[(3S)-5-[(6-bromo-2-methoxynaphthalen-1-yl)methyl]-1-[[4-(2,2-dimethylpropanoyl)phenyl]-hydroxymethyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide

(2S)-N-[(3S)-5-[(6-bromo-2-methoxynaphthalen-1-yl)methyl]-1-[[4-(2,2-dimethylpropanoyl)phenyl]-hydroxymethyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide (PubChem CID 155199103) has the molecular formula C37H41BrN4O5 and a molecular weight of 701.66 g/mol. Its IUPAC name is (2S)-N-[(3S)-5-[(6-bromo-2-methoxynaphthalen-1-yl)methyl]-1-[[4-(2,2-dimethylpropanoyl)phenyl]-hydroxymethyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide.

Molecular Properties

Compound Name(2S)-N-[(3S)-5-[(6-bromo-2-methoxynaphthalen-1-yl)methyl]-1-[[4-(2,2-dimethylpropanoyl)phenyl]-hydroxymethyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide
PubChem CID155199103
Molecular FormulaC37H41BrN4O5
Molecular Weight701.66 g/mol
Exact Mass700.23
IUPAC Name(2S)-N-[(3S)-5-[(6-bromo-2-methoxynaphthalen-1-yl)methyl]-1-[[4-(2,2-dimethylpropanoyl)phenyl]-hydroxymethyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide
SMILESCN[C@@H](C)C(=O)N[C@H]1CN(C(O)c2ccc(C(=O)C(C)(C)C)cc2)c2ccccc2N(Cc2c(OC)ccc3cc(Br)ccc23)C1=O
InChIInChI=1S/C37H41BrN4O5/c1-22(39-5)34(44)40-29-21-42(35(45)24-13-11-23(12-14-24)33(43)37(2,3)4)31-10-8-7-9-30(31)41(36(29)46)20-28-27-17-16-26(38)19-25(27)15-18-32(28)47-6/h7-19,22,29,35,39,45H,20-21H2,1-6H3,(H,40,44)/t22-,29-,35?/m0/s1
InChIKeyGBUSEYJMYGTENS-HUINHVGJSA-N
XLogP5.98
TPSA111.21 Ų
H-Bond Donors3
H-Bond Acceptors7
Rotatable Bonds9
Heavy Atoms47
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500701.66
LogP ≤ 55.98
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 107

Analyze (2S)-N-[(3S)-5-[(6-bromo-2-methoxynaphthalen-1-yl)methyl]-1-[[4-(2,2-dimethylpropanoyl)phenyl]-hydroxymethyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2S)-N-[(3S)-5-[(6-bromo-2-methoxynaphthalen-1-yl)methyl]-1-[[4-(2,2-dimethylpropanoyl)phenyl]-hydroxymethyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide?
The IUPAC name of (2S)-N-[(3S)-5-[(6-bromo-2-methoxynaphthalen-1-yl)methyl]-1-[[4-(2,2-dimethylpropanoyl)phenyl]-hydroxymethyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide (CID 155199103) is (2S)-N-[(3S)-5-[(6-bromo-2-methoxynaphthalen-1-yl)methyl]-1-[[4-(2,2-dimethylpropanoyl)phenyl]-hydroxymethyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide.
What is the SMILES notation for (2S)-N-[(3S)-5-[(6-bromo-2-methoxynaphthalen-1-yl)methyl]-1-[[4-(2,2-dimethylpropanoyl)phenyl]-hydroxymethyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide?
The canonical SMILES for (2S)-N-[(3S)-5-[(6-bromo-2-methoxynaphthalen-1-yl)methyl]-1-[[4-(2,2-dimethylpropanoyl)phenyl]-hydroxymethyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide is CN[C@@H](C)C(=O)N[C@H]1CN(C(O)c2ccc(C(=O)C(C)(C)C)cc2)c2ccccc2N(Cc2c(OC)ccc3cc(Br)ccc23)C1=O.
What is the InChIKey of (2S)-N-[(3S)-5-[(6-bromo-2-methoxynaphthalen-1-yl)methyl]-1-[[4-(2,2-dimethylpropanoyl)phenyl]-hydroxymethyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide?
The InChIKey is GBUSEYJMYGTENS-HUINHVGJSA-N. The full InChI is InChI=1S/C37H41BrN4O5/c1-22(39-5)34(44)40-29-21-42(35(45)24-13-11-23(12-14-24)33(43)37(2,3)4)31-10-8-7-9-30(31)41(36(29)46)20-28-27-17-16-26(38)19-25(27)15-18-32(28)47-6/h7-19,22,29,35,39,45H,20-21H2,1-6H3,(H,40,44)/t22-,29-,35?/m0/s1.
What are the key properties of (2S)-N-[(3S)-5-[(6-bromo-2-methoxynaphthalen-1-yl)methyl]-1-[[4-(2,2-dimethylpropanoyl)phenyl]-hydroxymethyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide?
(2S)-N-[(3S)-5-[(6-bromo-2-methoxynaphthalen-1-yl)methyl]-1-[[4-(2,2-dimethylpropanoyl)phenyl]-hydroxymethyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide has a molecular weight of 701.66 g/mol, XLogP of 5.98, 9 rotatable bonds, 3 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for (2S)-N-[(3S)-5-[(6-bromo-2-methoxynaphthalen-1-yl)methyl]-1-[[4-(2,2-dimethylpropanoyl)phenyl]-hydroxymethyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]-2-(methylamino)propanamide is sourced from PubChem (CID 155199103), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).